Spatiotemporal burden, risk factors, and genetic causality of non‐alcoholic fatty liver disease and type 2 diabetes mellitus comorbidity in Europe: A multi‐database analysis

Documenti analoghi

• Impact of non‐alcoholic fatty liver disease and fibrosis on mortality and kidney outcomes in patients with type 2 diabetes and chronic kidney disease: A multi‐cohort longitudinal study
  di: Lijun Zhao, et al.
  Pubblicazione: (2024)
• Efficacy and safety of liraglutide in non‐alcoholic fatty liver disease with or without type 2 diabetes: A systematic review and meta‐analysis
  di: Weihan Kong, et al.
  Pubblicazione: (2025)
• Copper homeostasis and cuproptosis‐related genes: Therapeutic perspectives in non‐alcoholic fatty liver disease
  di: Wangjing Tan, et al.
  Pubblicazione: (2024)
• A systematic literature review on the burden of diabetic ketoacidosis in type 2 diabetes mellitus
  di: Carol Wysham, et al.
  Pubblicazione: (2025)
• Global, regional and country‐specific burden of chronic kidney disease due to type 1 diabetes mellitus: A systematic analysis of the 2021 global disease burden study
  di: Jianran Sun, et al.
  Pubblicazione: (2025)